TI
DMTK

Trexquant Investment’s DermTech, Inc. Common Stock DMTK Stock Holding History

Trexquant Investment’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26,446
Closed -$147K – 1923
2022
Q2 		$147K Buy
+26,446
New +$217K 0.01% 1407
2021
Q2 		– Sell
-9,550
Closed -$485K – 1587
2021
Q1 		$485K Buy
+9,550
New +$499K 0.04% 520

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIA
Avalon Investment & Advisory Houston, Texas $3.65B AUM 0.47% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Trexquant Investment's DMTK Position: Q3 2022 in Review

Trexquant Investment sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2022, closing a stake of 26,446 shares — an estimated $147K sold.

Trexquant Investment first reported a position in DMTK in Q1 2021 and held it in 2 quarters. The position peaked at $485K in Q1 2021. 127 funds tracked by Wall St. Rank hold DMTK as of Q3 2022.

  • Trexquant Investment reported no remaining DermTech, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Trexquant Investment sold 26,446 DermTech, Inc. Common Stock shares in Q3 2022, an estimated $147K.
  • Trexquant Investment first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Trexquant Investment's DermTech, Inc. Common Stock position peaked at $485K in Q1 2021.
  • 127 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2022.

Based on Trexquant Investment's 13F filing for Q3 2022, filed 14 Nov 2022.